{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:26:47Z","timestamp":1789140407271,"version":"build-2803163510"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Currently, immune checkpoint inhibitors (ICIs) are the mainstay of treatment for Lynch syndrome patients. However, the tumor regression features in radiology and pathology are inconsistent for patients who are treated with ICIs, which sometimes confuses surgical decision-making. Here, we report a case in which a 36-year-old patient suffering from infertility was diagnosed with Lynch syndrome-associated synchronous endometrial cancer and colon cancer, and persistently enlarged left iliac paravascular lymph nodes were detected after receiving sintilimab treatment, a programmed cell death 1 (PD-1) receptor inhibitor. Fortunately, when she was about to undergo hysterectomy and bilateral salpingo-oophorectomy, intraoperative pathology examination did not reveal any cancer cells in these lymph nodes, and therefore, her reproductive organs were preserved. Later, the patient successfully conceived and gave birth to a healthy male neonate with no immune-related adverse events (irAEs) during an 11-month follow-up. This case indicates that surgeons should carefully inspect the imaging characteristics after immunotherapy and that organ preservation is possible even for patients who fail to achieve complete clinical regression, which is especially important for female patients of childbearing age.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1010490","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T06:37:53Z","timestamp":1665988673000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Case report: Reproductive organ preservation and subsequent pregnancy for an infertility patient with lynch syndrome-associated synchronous endometrial cancer and colon cancer after treatment with a PD-1 checkpoint inhibitor"],"prefix":"10.3389","volume":"13","author":[{"given":"Di","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-qing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-fan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0004.2009.01230.x","article-title":"Review of the lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications","volume":"76","author":"Lynch","year":"2009","journal-title":"Clin Genet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21448","article-title":"Recent progress in lynch syndrome and other familial colorectal cancer syndromes","volume":"68","author":"Boland","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.10.8597","article-title":"Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer","volume":"25","author":"Lu","year":"2007","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.01.036","article-title":"Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990-2019","volume":"161","author":"Gu","year":"2021","journal-title":"Gynecol Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.09.008","article-title":"Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy","volume":"104","author":"Menzer","year":"2018","journal-title":"Eur J Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S53164","article-title":"Clinical applications of PD-1-based therapy: A focus on pembrolizumab (MK-3475) in the management of melanoma and other tumor types","volume":"8","author":"Gangadhar","year":"2015","journal-title":"Onco Targets Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"B9","volume-title":"CARE checklist - CARE case report guidelines","year":""},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-017-1010-7","article-title":"GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF\/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial","volume":"34","author":"Prapas","year":"2017","journal-title":"J Assist Reprod Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000506803","article-title":"Closed vs. open oocyte vitrification methods are equally effective for blastocyst embryo transfers: Prospective study from a sibling oocyte donation program","volume":"85","author":"Gullo","year":"2020","journal-title":"Gynecol Obstet Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-020-00819-x","article-title":"Aberrant telomere length in circulating cell-free DNA as possible blood biomarker with high diagnostic performance in endometrial cancer","volume":"26","author":"Benati","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000642","article-title":"Presence of glandular cells at the preoperative cervical cytology and local recurrence in endometrial cancer","volume":"39","author":"Casarin","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.23736\/S0026-4806.20.07125-6","article-title":"Novelties of ultrasound imaging for endometrial cancer preoperative workup","volume":"112","author":"Capozzi","year":"2021","journal-title":"Minerva Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"11825","DOI":"10.3390\/ijms222111825","article-title":"Fertility-sparing approach in women affected by stage I and low-grade endometrial carcinoma: An updated overview","volume":"22","author":"Gullo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"12248","DOI":"10.3390\/ijms222212248","article-title":"Fertility sparing treatments in endometrial cancer patients: The potential role of the new molecular classification","volume":"22","author":"Cavaliere","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.3390\/ijms23052653","article-title":"Biomolecular and genetic prognostic factors that can facilitate fertility-sparing treatment (FST) decision making in early stage endometrial cancer (ES-EC): A systematic review","volume":"23","author":"Tanos","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1624","article-title":"Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria","volume":"15","author":"Wolchok","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3892\/mco.2021.2404","article-title":"Malignant melanoma treated with pembrolizumab during pregnancy: A case report and review of the literature","volume":"15","author":"Anami","year":"2021","journal-title":"Mol Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000586","article-title":"Pregnancy with successful foetal and maternal outcome in a melanoma patient treated with nivolumab in the first trimester: case report and review of the literature","volume":"29","author":"Xu","year":"2019","journal-title":"Melanoma Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000657","article-title":"Conception and viable twin pregnancy in a patient with metastatic melanoma while treated with CTLA-4 and PD-1 checkpoint inhibition","volume":"30","author":"Bucheit","year":"2020","journal-title":"Melanoma Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000801","article-title":"Uncomplicated pregnancy and delivery under ongoing nivolumab therapy for metastatic melanoma","volume":"32","author":"Gambichler","year":"2022","journal-title":"Melanoma Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2018.03.003","article-title":"Viable pregnancy in a patient with metastatic melanoma treated with double checkpoint immunotherapy","volume":"45","author":"Burotto","year":"2018","journal-title":"Semin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14463","article-title":"Pregnancy in a patient with metastatic uveal melanoma treated with nivolumab","volume":"19","author":"Haiduk","year":"2021","journal-title":"J Dtsch Dermatol Ges"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1432","article-title":"Successful pregnancy and fetal outcome following previous treatment with pembrolizumab for relapsed hodgkin's lymphoma","volume":"5","author":"Le-Nguyen","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2021.1981361","article-title":"Pregnancy outcome after early exposure to nivolumab, a PD-1 checkpoint inhibitor for relapsed hodgkin's lymphoma","volume":"60","author":"Hutson","year":"2022","journal-title":"Clin Toxicol (Phila)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004434","article-title":"Term pregnancy after complete response of placental site trophoblastic tumor to immunotherapy","volume":"138","author":"Polnaszek","year":"2021","journal-title":"Obstet Gynecol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100262","article-title":"Immune checkpoint inhibitor administration during pregnancy: A case series","volume":"6","author":"Andrikopoulou","year":"2021","journal-title":"ESMO Open"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.21176","article-title":"An evaluation of the impact of PD-1 pathway blockade on reproductive safety of therapeutic PD-1 inhibitors","volume":"107","author":"Poulet","year":"2016","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00525-8","article-title":"Immunotherapy for cancer treatment during pregnancy","volume":"22","author":"Borgers","year":"2021","journal-title":"Lancet Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.20201","article-title":"An interspecies comparison of placental antibody transfer: New insights into developmental toxicity testing of monoclonal antibodies","volume":"86","author":"Pentsuk","year":"2009","journal-title":"Birth Defects Res B Dev Reprod Toxicol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1010490\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T06:37:57Z","timestamp":1665988677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1010490\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2022.1010490"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1010490","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]},"article-number":"1010490"}}